We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Tercica, Genentech File Motion To Block Insmed Growth Therapy

Law360 (May 31, 2005, 12:00 AM EDT) -- Drug makers Tercica Inc. and Genentech Inc. have have filed a motion for a preliminary injunction to block Insmed Inc. from bringing its SomatoKine growth therapy to market ahead of a...
To view the full article, register now.